News & Analysis as of

Private Equity Funds

McGuireWoods LLP

Linden Closes New Fund With $5.4 Billion

McGuireWoods LLP on

Linden Capital Partners has announced the close of a new buyout fund. The fund — Linden Capital Partners VI — is the firm’s sixth buyout fund....more

Cadwalader, Wickersham & Taft LLP

Secondaries Shift, April 2025 - Secondaries Outlook: A Market All Grown Up

We are now more than a full quarter into 2025, and it has been a very busy start to the year for the CWT fund finance practice, thanks in part to a busy quarter for secondaries fund finance deals. This is on the back of an...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Revelstoke Invests in AOM Infusion

McGuireWoods LLP on

Revelstoke Capital Partners has announced a recapitalization of AOM Infusion. AOM, founded in 1994 and based in Fort Worth, Texas, is a specialty infusion provider focused on chronic therapy management....more

BCLP

AIFMD II Leverage Limits and Single Borrower Exposure Restriction

BCLP on

AIFMD II introduces substantial changes to the EU-wide regulatory framework for alternative investment fund managers (“AIFMs”) that was established under AIFMD. The changes cover a wide range of areas but will have a...more

Dechert LLP

UK regulatory divergence – HMT and FCA publish proposals to revise the regulatory framework for UK AIFMs

Dechert LLP on

On 7 April 2025 two papers were published that could have a significant impact on the future of asset management in the UK and herald the beginning of real regulatory divergence between UK and EU regulation of managers of...more

Walkers

Private equity secondary transactions and Jersey specific issues

Walkers on

Private equity (PE) secondary transactions have grown significantly in recent years, driven by increasing liquidity needs among investors triggered by geopolitical uncertainties, public market volatility significant declines...more

McGuireWoods LLP

Linden Closes New Fund With $400 Million

McGuireWoods LLP on

Linden Capital Partners has announced the close of a new fund. The fund — Linden Structured Capital Fund II — closed with $400 million of commitments....more

Mayer Brown

The Spectrum of Loan Portfolio Backleverage Options: A Primer for Private Credit Funds

Mayer Brown on

EXECUTIVE SUMMARY - There is a spectrum of potential financing structures for a private credit fund (a “Credit Fund”) to obtain liquidity, including at various levels in the fund structure, such as at the fund level or by...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Wellspring Acquires Summit Spine & Joint

McGuireWoods LLP on

Wellspring Capital Management has acquired Summit Spine & Joint Centers, according to a news release. Summit, founded in 2014 and based in Lawrenceville, Georgia, is a provider of minimally invasive spine services in the...more

Paul Hastings LLP

UK FCA’s Review of Valuation Processes for Private Market Assets — Key Findings and Implications for Private Equity and Private...

Paul Hastings LLP on

On March 5, 2025, the U.K. Financial Conduct Authority (FCA) released its much-anticipated findings from a multifirm review examining valuation processes for private market assets. This review, launched amid growing concerns...more

Kramer Levin Naftalis & Frankel LLP

Strategies for Preparing the New Hart-Scott-Rodino Forms

On Feb. 10, 2025, the new premerger notification and report forms under the Hart-Scott-Rodino (HSR) Act became effective. The new HSR forms make significant changes to the reporting obligations of both acquiring and acquired...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: SK Capital Invests in Spectrum Vascular

McGuireWoods LLP on

An affiliate of SK Capital Partners has invested in Spectrum Vascular, according to a news release. Spectrum, founded in 2023 and based in White Plains, New York, is a medical device company focused on vascular access...more

Proskauer - Regulatory & Compliance

Momentum on Voting on the Omnibus Delay and Updating Corporate Sustainability Reporting Requirements

Vote to delay - On 1 April 2025, the European Parliament approved the “urgent procedure” with regards to the “Omnibus” package of proposals to streamline corporate sustainability requirements....more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Insight Partners Sells CentralReach for $1.65 Billion

McGuireWoods LLP on

Insight Partners has sold CentralReach to Roper Technologies for around $1.65 billion, according to a news release. CentralReach, founded in 2012 and based in Fort Lauderdale, Florida, is a provider of software to...more

King & Spalding

New Marketing Rule FAQs Facilitate Compliance on Net Performance

King & Spalding on

On March 19, 2025, the SEC Staff published two Marketing Rule FAQs that address some of the more challenging aspects of the Marketing Rule requirement to present net performance information. Specifically, the FAQs provide a...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: AIM Equity Acquires AMOpportunities

McGuireWoods LLP on

AIM Equity Partners has made a majority-control growth investment in AMOpportunities (AMO), according to a news release....more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Knox Lane Invests in HCEsquared

McGuireWoods LLP on

Knox Lane has announced an investment in Healthcare Experts Squared (HCEsquared). HCEsquared, founded in 2001 and based in Vail, Colorado, is an education, information and services platform serving healthcare...more

Cadwalader, Wickersham & Taft LLP

Capital Call Securitisation, March 2025 - Subscription Finance Facilities – the Allure to Securitise: A European Perspective

Securitisation of subscription finance facilities is en vogue in fund finance. We have written previously on this topic, offering a primer on capital call securitisations and a Q&A regarding a first publicly rated cash...more

ArentFox Schiff

SEC No Action Letter Guidance Streamlines Rule 506(c) Accredited Investor Verification

ArentFox Schiff on

On March 12, the US Securities and Exchange Commission (SEC), via a No Action Letter, issued interpretive guidance clarifying what constitutes “reasonable steps” issuers can take to verify purchasers’ accredited investor...more

BCLP

New SEC Staff Guidance on Verification of Investor Accreditation in Private Placements Involving General Solicitation

BCLP on

On March 12, 2025, the SEC staff confirmed in a no-action letter that issuers may rely on high minimum investment levels, as well as investor self-certification of accredited status, in private offerings involving general...more

Goodwin

Germany Creates Improved Framework Conditions for Investments in Infrastructure Funds

Goodwin on

Conditions for direct or indirect investment in infrastructure have significantly improved for German regulated investors covered by the Investment Ordinance (Anlageverordnung) in regard to the investment of their secured...more

Goodwin

Private Funds Are Getting More Freedom to Recycle

Goodwin on

Managers are often able to secure more-flexible recycling provisions, enabling them to reinvest a wider range of proceeds, often within an overall cap on amounts....more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: InTandem Invests in Clinilabs

McGuireWoods LLP on

InTandem Capital Partners has announced it has completed an investment in Clinilabs. Clinilabs, founded in 2000 and based in Eatontown, New Jersey, is a contract research organization focused on central nervous system...more

Tannenbaum Helpern Syracuse & Hirschtritt LLP

SEC Resolves Uncertainty around Verification Requirement for Private Offerings under Rule 506(c)

On March 12, 2025, the Division of Corporation Finance (the “Division”) of the SEC issued a no-action letter (the “No-Action Letter”) providing new guidance on Rule 506(c) of Regulation D under the Securities Act....more

Akin Gump Strauss Hauer & Feld LLP

SEC Staff Provides Guidance on Private Offerings to Accredited Investors That Permit General Solicitation and Other Exemptions

On March 12, 2025, the U.S. Securities and Exchange Commission (SEC)’s Division of Corporation Finance (SEC Staff) published new and revised Compliance and Disclosure Interpretations (C&DIs) regarding private offering...more

1,364 Results
 / 
View per page
Page: of 55

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide